John Paulson’s Paulson & Co. disclosed in an SEC filing its holdings as of September 30, 2023. The fund exited one position during the third quarter, namely Newmont (NEM). Pauslon increased its stake in two holdings, namely Horizon Therapeutics (HZNP) and Madrigal Pharma (MDGL). The fund’s top holdings as of September 30, in order of size, were Horizon Therapeutics, Bausch Health (BHC), Brightsphere Investment (BSIG), Novagold (NG), and Perpetua Resources (PPTA).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NEM:
- Newmont price target lowered to C$75 from C$81 at National Bank
- Newmont resumed with an Outperform at BMO Capital
- Newmont completes acquisition of Newcrest Mining
- Newmont price target lowered to $46 from $55 at TD Securities
- Newmont price target lowered to C$57 from C$59 at Raymond James
Questions or Comments about the article? Write to editor@tipranks.com